ARTICLE

FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

By Yasemin Saplakoglu — 2019

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Read on www.livescience.com

FindCenter Post-Image

Inside The Movement To Decolonize Psychedelic Pharma

As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.

Article
Carolyn Gregoire
2020
FindCenter AddIcon
FindCenter Post-Image

Integration, Rippling

In the deep space of the psychedelic experience exists a teaching on unity principle and belonging with the earth.

Article
Francoise Bourzant
2020
FindCenter AddIcon

EXPLORE TOPIC

Psilocybin